Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) FCF Margin (2019 - 2025)

Legend Biotech filings provide 7 years of FCF Margin readings, the most recent being 3.98% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 5389.0% to 3.98% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.16%, a 1705.0% increase, with the full-year FY2025 number at 9.74%, up 1547.0% from a year prior.
  • FCF Margin hit 3.98% in Q4 2025 for Legend Biotech, down from 12.41% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 23.15% in Q1 2024 to a low of 400.74% in Q4 2021.
  • Median FCF Margin over the past 5 years was 57.82% (2023), compared with a mean of 103.87%.
  • Biggest five-year swings in FCF Margin: crashed -23834bps in 2023 and later skyrocketed 39452bps in 2024.
  • Legend Biotech's FCF Margin stood at 400.74% in 2021, then surged by 74bps to 104.28% in 2022, then surged by 100bps to 0.17% in 2023, then crashed by -34880bps to 57.87% in 2024, then surged by 93bps to 3.98% in 2025.
  • The last three reported values for FCF Margin were 3.98% (Q4 2025), 12.41% (Q3 2025), and 1.5% (Q2 2025) per Business Quant data.